Biliary Tract Cancer & Pemigatinib (unrelated) Updates
Sep 09, 2022•16 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Updates on billiary track cancer - a role for durvalumab?
And pemigatinib - an approval in r/r myeloid/lymphoid neoplasms.
Plus, an oral suspension of ibrutinib is approved and more evidence ICI combination should be given early in BRAF-mutated metastatic melanoma (rather than waiting until disease progression on TKIs)
For the best experience, listen in Metacast app for iOS or Android